Historique de carrière de Da Qing Cai
Anciens postes connus de Da Qing Cai
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Directeur/Membre du Conseil | 20/08/2020 | 23/03/2023 |
| Independent Dir/Board Member | 20/08/2020 | 23/03/2023 | |
| BIONANO GENOMICS, INC. | Directeur/Membre du Conseil | 01/08/2018 | 01/08/2019 |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 01/06/2016 | 01/03/2019 |
| BERRY GENOMICS CO.,LTD | Directeur/Membre du Conseil | 01/07/2017 | 01/04/2018 |
Formation de Da Qing Cai
| University of Science & Technology of China | Undergraduate Degree |
| Yale University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistiques
Internationale
| Chine | 5 |
| Etats-Unis | 4 |
Opérationnelle
| Director/Board Member | 4 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BERRY GENOMICS CO.,LTD | Health Technology |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| BIONANO GENOMICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Bourse
- Insiders
- Da Qing Cai
- Expérience
